Safe and Effective Delivery of Aerosolized Medications in the Era of COVID-1
Arzu Ari, Ph.D., RRT, PT, CPFT, FAARC, FCCP
During the COVID-19 pandemic there has been concern regarding staff exposure from delivering aerosolized medications to patients with the disease. This webinar will provide practical strategies on how to deliver aerosolized medications to patients with COVID-19 safely and effectively. Infection control and prevention in the era of COVID-19 will also be discussed.
Upon completion of this educational activity, the participant will be able to:
Describe how aerosols and droplets may be the source of respiratory pathogens.
Describe practical strategies on how to deliver aerosolized medications to patients with COVID-19 safely and effectively.
Discuss infection control and prevention to mitigate provider risk associated with aerosolized medications for patients with COVID-19.
Dr. Arzu Ari is currently Professor Texas State University in Round Rock, TX. She is a physical therapist and a respiratory therapist by training with 24 years of experience as a manager, clinician, educator and researcher. Dr. Ari’s primary area of research is aerosol medicine. In particular, she evaluates in-vitro characterization of medical aerosols from various types of aerosol delivery systems used in the treatment of pulmonary diseases to help improve drug delivery in adult, pediatrics and infants. Her research laboratory is one of only a few in the world that can bring together the pharmaceutical, aerosol and respiratory care talent and infrastructure needed to support innovative research, build consensus and make strides in the field. Dr. Ari has published clinical practice guidelines on aerosol drug delivery and has published a range of abstracts, original research and review articles in numerous peer-reviewed journals. She has spoken on these topics at a variety of national and international medical conferences.
Supported by an educational grant from